These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 13478285

  • 1. Necrotizing properties of metaraminol (aramine) and arterenol (norepinephrine); comparative study.
    BRYANT MF, HOWARD JM.
    AMA Arch Surg; 1957 Dec; 75(6):1020-2. PubMed ID: 13478285
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of the cerebral hemodynamic response to aramine and norepinephrine in the normotensive and hypotensive subject.
    MOYER JH, MORRIS G, SNYDER H, SMITH CP.
    Circulation; 1954 Aug; 10(2):265-70. PubMed ID: 13182760
    [No Abstract] [Full Text] [Related]

  • 3. Influence of respiratory acidosis on ECG and pressor responses to epinephrine, norepinephrine and metaraminol.
    HOULE DB, WEIL MH, BROWN EB, CAMPBELL GS.
    Proc Soc Exp Biol Med; 1957 Mar; 94(3):561-4. PubMed ID: 13408326
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of cardiac shock by metaraminol.
    BESTERMAN EM.
    Br Med J; 1959 Apr 25; 1(5129):1081-3. PubMed ID: 13638636
    [No Abstract] [Full Text] [Related]

  • 5. Comparative study of coronary action of metaraminol and noradrenaline on the isolated heart.
    CAYUELA ML, DOUGLAS CR, TALESNIK J.
    Acta Physiol Lat Am; 1961 Apr 25; 11():120-6. PubMed ID: 13877529
    [No Abstract] [Full Text] [Related]

  • 6. Alterations in central blood volume and cardiac output induced by positive pressure breathing and counteracted by metaraminol (aramine).
    BRAUNWALD E, BINION JT, MORGAN WL, SARNOFF SJ.
    Circ Res; 1957 Nov 25; 5(6):670-5. PubMed ID: 13473068
    [No Abstract] [Full Text] [Related]

  • 7. Clinical studies on a vasopressor agent: metaraminol (aramine). I. Observations in normotensive subjects.
    WEIL MH, SPINK WW.
    Am J Med Sci; 1955 Jun 25; 229(6):661-9. PubMed ID: 14376394
    [No Abstract] [Full Text] [Related]

  • 8. Circulatory depression induced by high levels of positive pressure breathing counteracted by metaraminol (aramine).
    MORGAN WL, BINION JT, SARNOFF SJ.
    J Appl Physiol; 1957 Jan 25; 10(1):26-30. PubMed ID: 13405825
    [No Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of aramine, a new sympathomimetic amine.
    TAYLOR GW.
    AMA Arch Otolaryngol; 1952 Aug 25; 56(2):213-4. PubMed ID: 14943343
    [No Abstract] [Full Text] [Related]

  • 10. Clinical studies on vasopressor agent: metaraminol (aramine). III. Observations on its oral use in the treatment of hypotension.
    WEIL MH.
    Am J Med Sci; 1957 Apr 25; 233(4):367-74. PubMed ID: 13410911
    [No Abstract] [Full Text] [Related]

  • 11. Clinical studies on a vasopressor agent: metaraminol (aramine). II. Observations on its use in the management of shock.
    WEIL MH.
    Am J Med Sci; 1955 Oct 25; 230(4):357-69. PubMed ID: 13258566
    [No Abstract] [Full Text] [Related]

  • 12. [Metaraminol (aramine) therapy of shock due to coronary occlusion].
    MUNE O, NORREGAARD S.
    Nord Med; 1959 Aug 20; 62():1255-60. PubMed ID: 14425245
    [No Abstract] [Full Text] [Related]

  • 13. The cardiovascular and renal hemodynamic effects of aramine.
    LIVESAY WR, MOYER JH, CHAPMAN DW.
    Am Heart J; 1954 May 20; 47(5):745-56. PubMed ID: 13148114
    [No Abstract] [Full Text] [Related]

  • 14. Effectiveness of aramine in the treatment of shock.
    MOYER JH, BEAZLEY HL.
    Am Heart J; 1955 Jul 20; 50(1):136-44. PubMed ID: 14387943
    [No Abstract] [Full Text] [Related]

  • 15. Effect of aramine on the survival of dogs subjected to hemorrhagic hypotension.
    SARNOFF SJ, KAUFMAN HE.
    Circ Res; 1954 Sep 20; 2(5):420-3. PubMed ID: 13190623
    [No Abstract] [Full Text] [Related]

  • 16. Effect of aramine-induced smooth muscle contraction on length-tension diagrams of venous strips.
    LEONARD E, SARNOFF SJ.
    Circ Res; 1957 Mar 20; 5(2):169-74. PubMed ID: 13414090
    [No Abstract] [Full Text] [Related]

  • 17. RELEASE OF METARAMINOL (ARAMINE) FROM THE HEART BY SYMPATHETIC NERVE STIMULATION.
    CROUT JR, ALPERS HS, TATUM EL, SHORE PA.
    Science; 1964 Aug 21; 145(3634):828-9. PubMed ID: 14163327
    [Abstract] [Full Text] [Related]

  • 18. Ventricular function. V. The circulatory effects of aramine; mechanism of action of vasopressor drugs in cardiogenic shock.
    SARNOFF SJ, CASE RB, BERGLUND E, SARNOFF LC.
    Circulation; 1954 Jul 21; 10(1):84-93. PubMed ID: 13172865
    [No Abstract] [Full Text] [Related]

  • 19. The use of aramine in clinical shock.
    FANKHAUSER A, FISHMAN SI, MADONIA PF, SCHWARTZ G, STECHEL GH, TURKOWITZ H.
    Circulation; 1956 Jun 21; 13(6):834-6. PubMed ID: 13356437
    [No Abstract] [Full Text] [Related]

  • 20. Aramine peripheral vaso spastic effects during therapy. A case report.
    GERSON IM.
    J Germantown Hosp; 1962 Aug 21; 3():93-6. PubMed ID: 13898081
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.